INTERNATIONAL PATENT: FIBROGEN, INC. FILES APPLICATION FOR "[(4-HYDROXY-1-METHYL-7-PHENOXYISOQUINOLINE-3- CARBONYL)AMINO]ACETIC ACID (ROXADUSTAT) FOR THE TREATMENT OF ANEMIA IN SUBJECTS WITH MYELODYSPLASTIC SYNDROME (MDS)"

GENEVA, June 4 -- FIBROGEN, INC. (350 Bay Street, Suite 100 #6009San Francisco, California 94133) filed a patent application (PCT/US2024/056333) for "[(4-HYDROXY-1-METHYL-7-PHENOXYISOQUINOLINE-3- CARBONYL)AMINO]ACETIC ACID (ROXADUSTAT) FOR THE TREATMENT OF ANEMIA IN SUBJECTS WITH MYELODYSPLASTIC SYNDROME (MDS)" on Nov 18, 2024. With publication no. WO/2025/111214, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHU, Lixia (c/o FibroGen, Inc.350 Bay Street, Suite 100 #6009San Francisco, California 94133)

Abstract: The p...